Ep. 5: Paul Bleicher, Phase Forward — Revolutionizing clinical trials & biotech innovation

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/e0/c3/3f/e0c33f85-97c9-3031-4522-0a4180d5d966/mza_16562934954751211350.png/600x600bb.jpg

Petri Podcast

Petri Bio

7 episodes

8 months ago

Spotlighting inspiring founders who are innovating around improving human health and sustainability.

All content for Petri Podcast is the property of Petri Bio and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Spotlighting inspiring founders who are innovating around improving human health and sustainability.

Ep. 5: Paul Bleicher, Phase Forward — Revolutionizing clinical trials & biotech innovation

Petri Podcast

31 minutes 1 second

4 years ago

Ep. 5: Paul Bleicher, Phase Forward — Revolutionizing clinical trials & biotech innovation

A constant innovator in patient data and healthcare, Paul Bleicher reflects on Phase Forward’s modernization of clinical trials and offers advice for “crossing the chasm” to tech adoption with risk-averse communities. Phase Forward went public and was later acquired by Oracle, and Paul went on to become the CMO of Humedica (acq Optum), and the CEO of OptumLabs. As a serial entrepreneur, Paul offers insights on the stages of early startup and on humbly knowing your own strengths - even if it means stepping aside as CEO to help your company crush it.